UPC APP 59539/2024

—·EP3346403: DATA PROCESSING, ANALYSIS METHOD OF GENE EXPRESSION DATA TO IDENTIFY ENDOGENOUS REFERENCE GENES

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
GXD-Bio Corporation
Vertreter: Rauh (Vossius & Brinkhof UPC Litigators)
Beklagte
Myriad International GmbH
Myriad GmbH
Myriad Service GmbH
Myriad Genetics GmbH
Myriad Genetics S.A.S.
Myriad Genetics B.V.
Myriad Genetics S.r.l.
Myriad Genetics, Inc.
Eurobio Scientific
Vertreter: Hölder (Hoffmann Eitle)
Division: Munich LD
Richter: Ulrike Voß · Presiding judge and judge-rapporteur
Technology: Biotechnology
Sprache: —
Erste Entscheidung: 26. Nov. 2024

Entscheidungen

2024-11-26
KostenGeneric application
The Munich Local Division considered the defendants' application for security for costs from the claimant GXD-Bio Corporation (a Korean IP monetization/NPE company), finding the claimant had insufficient financial resources based on credit rating and corporate structure evidence. The court addressed the appropriate level of security under Rule 158 RoP.
Rechtsfragen:Security for costs from NPE/IP monetization claimant under Rule 158 RoPAssessment of financial resources of foreign claimant

Dokumente